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Introduction
E-cadherin, the primary cell adhesion molecule within
adherens junctions, is essential for maintaining apical-basal
polarity in epithelial cells (Takeichi, 1988; Hay, 1995). During
epithelial-mesenchymal transformation (EMT), loss of E-
cadherin expression correlates with a transition to front-end to
back-end polarity, leading to subsequent migration of the
newly created mesenchymal cells (Thiery, 2003). This
molecular mechanism is essential for correct development
during embryogenesis and is a common initiator of tumor
metastasis (Birchmeier et al., 1996; Thiery, 2002).
Many transcription factor proteins, such as Snail, Slug,
E12/E47, SIP-1, ZEB-1 and Twist directly bind to the E-
cadherin gene promoter to inhibit its transcription (Peinado et
al., 2004). Lymphoid enhancer factor 1 (LEF1), a molecule
typically associated with Wnt signaling (Behrens et al., 1996;
Eastman and Grosschedl, 1999), has been proved do the same
when activated by -catenin (Jamora et al., 2003; Medici et al.,
2006). A strong correlation has been made between -
catenin–LEF1 signaling and acquisition of the invasive
morphology in colon carcinoma cells (Kim et al., 2002) and
malignant melanomas (Murakami et al., 2001; Chen et al.,
2003). LEF1 is also localized in most embryonic tissues that
undergo EMT, including the neural crest, somites, primitive
streak (Mohamed et al., 2004) and palate (Nawshad and Hay,
2003).
During embryogenesis, the formation of the palate occurs
when two opposing palatal shelves grow beneath the nasal
septum to the point of touching and adherence at their medial
edges. When this occurs, the medial-edge epithelium (MEE)
receives appropriate signals that cause its transformation to
mesenchyme, thus forming one confluent palate tissue, rather
than two palatal shelves. Failure of adherence (fusion) or EMT
leads to cleft palate (Nawshad et al., 2004).
The transformation of palate medial-edge epithelium to
mesenchyme has been well documented (Fitchett and Hay,
1989; Kaartinien et al., 1997; Nawshad et al., 2004).
However, signaling mechanisms that promote EMT during
palatogenesis have only recently been investigated in detail.
Transforming growth factor-beta3 (TGF3) has been
established to have an essential role in palate development,
including the transformation of MEE cells to the
mesenchymal morphology (Brunet et al., 1995; Kaartinen et
al., 1997; Nawshad and Hay, 2003). Upon adherence of
opposing palatal shelves and formation of the MEE seam, the
basal MEE cells show increased expression of TGF3
(LaGamba et al., 2005), which remains until EMT is
complete (Tudela et al., 2002). TGF3-knockout mice
(Proetzel et al., 1995; Taya et al., 1999), as well as some
naturally TGF3-null avian systems (Sun et al., 1998),
always have cleft palate. Furthermore, treatment of palates
from TGF3-knockout mice with exogenous TGF3 is
sufficient to rescue palatal fusion (Taya et al., 1999).
Unfused palatal seam cells lack the ability to undergo EMT
Dissociation of medial-edge epithelium (MEE) during
palate development is essential for mediating correct
craniofacial morphogenesis. This phenomenon is initiated
by TGF3 upon adherence of opposing palatal shelves,
because loss of E-cadherin causes the MEE seam to break
into small epithelial islands. To investigate the molecular
mechanisms that cause this E-cadherin loss, we isolated
and cultured murine embryonic primary MEE cells from
adhered or non-adhered palates. Here, we provide the first
evidence that lymphoid enhancer factor 1 (LEF1), when
functionally activated by phosphorylated Smad2 (Smad2-
P) and Smad4 (rather than -catenin), binds with the
promoter of the E-cadherin gene to repress its
transcription in response to TGF3 signaling.
Furthermore, we found that TGF3 signaling stimulates
epithelial-mesenchymal transformation (EMT) and cell
migration in these cells. LEF1 and Smad4 were found to
be necessary for up-regulation of the mesenchymal
markers vimentin and fibronectin, independently of -
catenin. We proved that TGF3 signaling induces EMT in
MEE cells by forming activated transcription complexes
of Smad2-P, Smad4 and LEF1 that directly inhibit E-
cadherin gene expression.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/120/9/1646/DC1
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1647Smad2-Smad4-LEF1 causes E-cadherin loss
because of insufficient levels of TGF signaling molecules.
Upon adherence of palatal shelves (0-12 hours post initial
contact) intracellular levels of TGF3, Smad anchor for
receptor activation (SARA), Smad2 and Smad4 are all
increased (LaGamba et al., 2005). TGF3 signaling has been
shown to promote transcription of the LEF1 gene in these cells
through a Smad-dependent mechanism. Surprisingly, it was
found that -catenin remained outside the nucleus during EMT
of palate MEE in vivo. Furthermore, inhibition of -catenin
using antisense oligodeoxynucleotide (AS ODN) did not
prevent EMT (Nawshad and Hay, 2003).
Based on prior findings of Smad proteins having the ability
to bind and activate LEF1 – rather than the traditional
activation by -catenin (Labbe et al., 2000; Nishita et al.,
2000), we previously suggested that TGF3 stimulates
transformation of MEE cells by promoting both transcription
and activation of LEF1 through a complex of dimerized
phosphorylated Smad2 (Smad2-P) and Smad4. LEF1 then
induces EMT, causing confluence of the palate (Nawshad and
Hay, 2003). However, until now, this idea remained unproved.
Here, we have provided evidence to support this hypothesis by
demonstrating that this activated Smad2-P–Smad4–LEF1
transcription complex directly interacts with the promoter of
the E-cadherin gene to repress its transcription, thus inducing
EMT.
Results
TGF3 signaling forms Smad2-P–Smad4–LEF1
transcription complexes
MEE cells were isolated and cultured into primary cell lines
from non-adhered (unfused, used as negative control) and
adhered (fused, 12 hours post initial contact) palatal shelves.
Whereas the term ‘fused’ is commonly used to describe
confluent palate tissue, here we use it to describe pre-EMT
MEE cells from adhered palatal shelves. We observed protein
expression of TGF3 by immunoblotting in these cells,
demonstrating no expression in unfused cells, but moderate
expression in fused cells (Fig. 1A). Small traces of TGF3 have
been described within in vivo MEE, however, upon culturing
unfused cells, TGF3 expression was lost, allowing these cells
to serve as an efficient negative control. Although some TGF3
signaling is seen in fused MEE cells, EMT does not occur at
this stage in vivo. Increases in TGF3 expression are seen as
palate development progresses (LaGamba et al., 2005). Also,
the peak of LEF1 expression and EMT occurs 24 hours after
adherence of palatal shelves is established (Nawshad and Hay,
2003). Since it was impossible to isolate MEE cells at this time
point (owing to dissociation of the MEE seam) and because
fused cells that were extracted for culture lose their continuous
endogenous upregulation of TGF3, we added exogenous
TGF3 for 24 hours to mimic the EMT observed in vivo.
Fig. 1. EMT is associated with nuclear localization of Smad2-P, Smad4 and LEF1, but not -catenin. (A) Immunoblotting demonstrated that
palatal adherence increases TGF3 expression. Unfused cells do not express TGF3, whereas fused cells show moderate protein expression.
(B) Immunocytochemistry showed nuclear localization of Smad2-P, Smad4, and LEF1 in fused MEE cells and in fused cells treated with
exogenous TGF3. Acquisition of the mesenchymal phenotype was observed when cells were treated with TGF3. -catenin remained in the
cytoplasm during EMT. Bar, 10 m. (C) Smad2-P and total Smad2 expression was observed by immunoblotting. No expression was detected in
unfused MEE cells for Smad2-P, whereas moderate levels were found in fused cells. Protein levels were heavily increased upon treatment with
TGF3. Increased levels of total Smad2 were observed upon palatal adherence. (D) LEF1 protein expression was not detected in unfused cells,
but showed steady increases in fused cells and in fused cells treated with TGF3. Addition of dominant-negative Smad4 prevented these
increases. (E) Immunoblotting from cytoplasmic and/or membrane (Cyt/Memb) and nuclear (Nucl) protein fractions showed no evidence of
nuclear -catenin under any condition. LEF1 was observed in the nuclear fraction of fused cells, with increased levels in cells treated with
TGF3. GAPDH and histone H3 were used as cytoplasmic and nuclear controls respectively.
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Immunocytochemistry showed no expression of Smad2-P or
LEF1 in unfused MEE cells. Upon fusion, these cells began to
express TGF signaling molecules, which showed nuclear
localization of Smad2-P, Smad4 and LEF1 in both fused cells,
and fused cells treated with TGF3 for 24 hours (to stimulate
EMT). A clear change in cellular morphology was observed
upon exposure to TGF3 anatomically demonstrating EMT.
Co-immunostaining for -catenin and LEF1 showed that these
two proteins appeared to remain in separate compartments
[with -catenin in the cytoplasm (green) and LEF1 in the
nuclei (red)] during EMT (Fig. 1B). Expression levels of
Smad2-P, total Smad2 (Fig. 1C) and LEF1 (Fig. 1D) were
observed by immunoblotting. Levels of total Smad2 increased
upon palatal adherence, consistent with previous findings
(LaGamba et al., 2005). We found no expression of Smad2-P
and LEF1 in unfused cells, moderate expression in fused cells,
and high expression in fused cells treated with exogenous
TGF3. LEF1 upregulation was prevented by the presence of
a dominant-negative Smad4, which lacks a DNA binding
domain, further supporting evidence that LEF1 expression is
Smad-dependent in this system (Nawshad and Hay, 2003). To
confirm compartmental localization of -catenin, cytoplasmic
and/or membrane and nuclear protein fractions were isolated
under all three conditions. Immunoblotting was performed
demonstrating that high levels of -catenin were present in the
cytoplasmic and/or membrane fractions, but no traces were
found in the nuclear fractions. LEF1 was found in the nuclear
fraction of fused cells, showing increased expression in cells
exposed to TGF3. GAPDH was used as a cytoplasmic marker
and histone H3 was used as a nuclear marker (Fig. 1E).
To demonstrate transcriptional activity Smad, a p3TP-Lux
reporter gene construct was transfected into unfused (negative
control), untreated fused and TGF3-treated fused MEE cells.
Since unfused cells do not possess TGF3 signaling potential
– as previously published (LaGamba et al., 2005), significant
levels of Smad transcriptional activity were not detected. By
contrast, fused cells demonstrated moderate levels of
transcription, which increased upon stimulation with exogenous
TGF3. The addition of a dominant negative Smad4 adenoviral
construct significantly inhibited p3TP-Lux activity (Fig. 2A). 
To confirm LEF1 transcriptional activity, pTOPFLASH-Lux
(containing LEF1-binding sites) and pFOPFLASH-Lux
(containing mutated LEF1-binding sites) constructs were
transfected into MEE cells. As expected, unfused MEE cells
demonstrated no transcriptional activity, whereas fused cells
showed that LEF1 is promoting transcription of the reporter
gene. Addition of exogenous TGF3 significantly increased
LEF1 transcriptional activity. Since LEF1 gene expression in
MEE cells is dependent upon Smad signaling (Nawshad and
Hay, 2003), addition of dominant-negative Smad4 greatly
reduced luciferase activity. The addition of a dominant-negative
LEF1 construct, producing a negative competitor protein that
lacks DNA-binding potential, also inhibited TOPFLASH
luciferase activity, whereas antisense oligodeoxynucleotide
against -catenin/-catenin (AS -catenin ODN) did not (Fig.
2B). Control immunoblots were conducted to demonstrate loss
of -catenin and -catenin in the presence of antisense
oligodeoxynucleotide (supplementary material Fig. S1).
Co-immunoprecipitation was performed to demonstrate the
formation of a Smad2-P–Smad4-LEF1 protein complex. Protein
extracts were immunoprecipitated from unfused, fused and fused
Journal of Cell Science 120 (9)
MEE cells treated with TGF3 using antibodies against Smad2-
P, Smad4 or LEF1. Each precipitate was then immunoblotted
with antibodies against -catenin, Smad4, Smad3-P, Smad2-P
and LEF1 proteins. Unfused extracts showed no protein binding
because LEF1 is not expressed in these cells. We found that
complexes of Smad2-P–Smad4–LEF1 were present in fused
cells, and were heavily increased upon treatment with TGF3.
No -catenin or Smad3-P was detected in the protein complex
(Fig. 3A). Immunoprecipitation and immunoblotting for -actin
served as an internal control (Fig. 3B).
Smad2-P–Smad4–LEF1 inhibits E-cadherin gene
expression to promote EMT
Since the most common molecular change used to
characterize and promote EMT is the loss of E-cadherin
Fig. 2. Confirmation of Smad and LEF1 transcriptional activities.
(A) p3TP-Lux reporter gene assay demonstrated that Smad
transcriptional activity increased from unfused to fused MEE cells,
with a sharp increase in activity upon stimulation with TGF3. A
dominant-negative Smad4 (DN Smad4) construct inhibited luciferase
activity (mean ± s.d.; n=3; *P<0.05 compared with Unfused;
**P<0.05 compared with p3TP-Lux). (B) pTOPFLASH-Lux (TF)
reporter gene assay showed that LEF1 transcriptional activity
continually increases as TGF3 signaling progresses. Mutated LEF1
binding sites of the pFOPFLASH-Lux reporter, as well as treatment
with DN Smad4 (Smad4 being necessary for LEF1 gene expression)
or dominant-negative LEF1 (DN LEF1) inhibited transcriptional
activity whereas antisense -catenin/-catenin oligodeoxynucleotide
(AS B-catenin ODN) did not (mean ± s.d.; n=3; *P<0.001 compared
with Unfused; **P<0.01 compared with TF).
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expression, we performed sequence analysis of the promoter
region of the murine E-cadherin gene. We identified one
distinct LEF1-binding region separated from the traditional
E-pal (E-box 1/2) TCF and/or LEF1 binding site (Peinado et
al., 2004). We also found that a Smad binding element (SBE;
Smad4-binding site) flanks the E-pal LEF1 site (Fig. 4A).
Binding of the Smad2-P–Smad4–LEF1 protein complex to
the endogenous loci of these regions was confirmed by
chromatin immunoprecipitation (ChIP). ChIP was performed
using antibodies against IgG (negative control), LEF1,
Smad4, Smad2-P and -catenin. PCR was then performed
with primers specific for the LEF1-binding (E-pal and non-
E-pal) and SBE-binding sites. Unfused cells showed no signal
with any antibodies, whereas fused cells showed moderate
signal with antibodies against LEF1, Smad4 and Smad2-P.
These signals were increased upon treatment of cells with
exogenous TGF3. -catenin was not found to be associated
with these binding regions. LEF1 and Smad4 bind to their
respective sites and, although Smad2 lacks a DNA-binding
domain (Derynk et al., 1998; Xu et al., 2000; Ten Dijke and
Hill, 2004), it still appears in the complex with respect to all
three binding sites (Fig. 4B). To avoid the possibility of the
observed PCR signals being the result of over-amplification,
we conducted real-time PCR for a quantitative assessment of
ChIP signals. Similar results to those found using standard
gel-based PCR were observed (supplementary material Fig.
S2).
Reporter gene assays were conducted to determine whether
this Smad2-P–Smad4–LEF1 transcription complex is
responsible for repressing E-cadherin gene transcription during
MEE cell EMT. E-cadherin gene promoter activity was
assessed using a pGL3-E-cad-Lux vector. Reporter gene
activity was detected at high levels in unfused MEE cells,
moderate levels in fused MEE cells, and was almost fully
inhibited upon treatment of fused MEE cells with TGF3.
Presence of dominant-negative Smad4 or dominant-negative
LEF1 constructs maintained promoter activity. Addition of AS
-catenin/-catenin ODN did not affect loss of promoter
activity (Fig. 5A). E-cadherin promoter activity was also
determined using another set of pGL3-E-cad-Lux reporter
plasmids, with the relative LEF1 or Smad4 binding sites
mutated. Interestingly, site-directed mutagenesis of the LEF1
(E-pal)-binding, LEF1 (non E-pal)-binding, or Smad4 (SBE)-
binding regions prevented loss of E-cadherin gene promoter
activity, suggesting that anchoring of the Smad2-
P–Smad4–LEF1 complex at all three binding sites is essential
for loss of E-cadherin (Fig. 5B). Real-time quantitative PCR
was performed to assess E-cadherin gene expression relative to
the unfused negative control. Fused cells showed moderately
less mRNA, whereas fused cells treated with TGF3 showed
a major reduction in gene expression. Addition of dominant-
negative LEF1 or dominant-negative Smad4 prevented loss of
E-cadherin gene expression, but AS -catenin/-catenin ODN
had no effect (Fig. 5C).
E-cadherin protein expression was assessed by
immunocytochemistry (Fig. 6A) and immunoblotting (Fig.
6B), showing moderate loss upon palatal fusion, and a
complete loss when exposed to exogenous TGF3.
Furthermore, addition of dominant-negative Smad4 or
dominant-negative LEF1 prevented E-cadherin loss, whereas
treatment with antisense oligodeoxynucleotide against -
catenin/-catenin transcripts did not. To confirm EMT, we also
assessed expression of mesenchymal markers vimentin and
fibronectin by immunoblotting. We found that, inversely to E-
cadherin, expression of these mesenchymal markers was
steadily increased upon palatal fusion and stimulation with
TGF3. Addition of dominant-negative Smad4 and dominant-
negative LEF1 prevented these increases, but antisense -
catenin/-catenin oligodeoxynucleotide (AS -catenin ODN)
had no effect (Fig. 6B). Cell migration was determined under
the same conditions by scratch wound (Fig. 7A) and transwell
(Fig. 7B) assays. We found that no migration occurred in
unfused or fused cells, whereas fused cells treated with TGF3
had high levels of migration. Dominant-negative LEF1 and
dominant-negative Smad4 prevented TGF3 induced
migration, but AS -catenin ODN did not. These results
provide a new model for E-cadherin repression during EMT of
palate MEE cells (Fig. 8).
Fig. 3. TGF3 signaling promotes formation of
a Smad2-P–Smad4–LEF1 transcription
complex. (A) Co-immunoprecipitation (IP) of
cell extracts from MEE cells was performed
using antibodies against Smad2-P, Smad4 or
LEF1. Immunoblot (IB) analysis showed that
Smad4, Smad2-P and LEF1 are bound together
in the extracts of fused MEE cells; increased
levels were observed when cells were exposed
to TGF3. Smad3-P and -catenin were not
found in this complex. Unfused MEE cells
showed no traces of interaction because LEF1 is
not expressed in these cells.
(B) Immunoprecipitation and immunoblotting
for -actin was used as an internal control.
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Discussion
Repression of E-cadherin gene transcription is perhaps the
most significant molecular change within cells that undergo
EMT. Loss of this epithelial marker has been proven to
stimulate (or be a contributing factor of) the transformation of
epithelium to the mesenchymal morphology (Hay, 1995;
Peinado et al., 2004). During craniofacial development, loss of
E-cadherin in palate MEE cells is essential for correct
formation of palatal tissue. Failure of this mechanism within
MEE cells can lead to palatal clefting (Nawshad et al., 2004).
Our results prove that LEF1, as part of an activated
transcription complex with Smad2-P and Smad4, acts as a
transcriptional repressor of the E-cadherin gene during EMT
of palate MEE cells. When stimulated by TGF3, these Smad
proteins bind and activate LEF1 to form a complex that can
either induce or repress transcription. This portrays a major
discovery in this system, because LEF1 has most commonly
been described as being activated by -catenin, as
demonstrated in traditional Wnt signaling. These data are
justified by previous findings that Wnt-knockout mice show no
evidence of palatal clefting, whereas LEF1- (Galceran et al.,
1999) and TGF3- (Taya et al., 1999) knockout mice have
severe craniofacial deformities, including cleft palate. Recent
Journal of Cell Science 120 (9)
findings of Smad2 knockdown by small
interfering RNA (siRNA) in preventing
palatal confluence (Shiomi et al., 2006)
further support these data. Why -catenin
remains in the cytoplasm during palatal
EMT remains to be determined. Also,
whereas E-cadherin may be suppressed
in other systems by -catenin and/or
LEF1 at a single binding site (Jamora et
al., 2003), Smad2-P–Smad4–LEF1
appears to require two LEF1-binding
regions for E-cadherin repression in
palate MEE cells.
Our data also show that TGF3
mediates EMT in a Smad and/or LEF1
dependent manner by promoting
expression of the mesenchymal markers
vimentin and fibronectin. We observed a
clear change in cell morphology from
epithelial cobblestone to mesenchymal
spindle shaped cells with filopodia, thus
providing anatomic proof of MEE
transdifferentiation. Increased levels of
cell migration associated with EMT were
also observed. Interestingly, although
fused cells showed moderate levels of
TGF3 signaling, no EMT was observed.
Only when exogenous TGF3 was added
to cultures did we observe this transition.
This is consistent with the in vivo model
of palatal EMT. Levels of endogenous
TGF3 are known to continually increase
in the MEE after adherence as palate
development progresses, and remains
until EMT is complete (Nawshad et al.,
2004). After isolation of primary MEE
cells from adhered palate tissue (12 hours
post initial contact) this continuous
upregulation of TGF3 was lost, producing only moderate
levels that appear insufficient for EMT induction. Since we
were unable to isolate cells from the peak stage of EMT (36
hours post initial contact), we added excess TGF3 (for 24
hours) to fused cells to mimic the higher levels observed in
vivo. Whereas it is not known why higher amounts of nuclear
Smad2-P–Smad4–LEF1 are necessary for EMT, it is clear that
the mechanism is TGF3 dose-dependent.
Disappearance of palate medial-edge epithelium during
craniofacial development is a topic of much controversy.
Whereas most of the early work in this field has provided
evidence for EMT (Fitchett and Hay, 1989; Griffith and Hay,
1992; Shuler et al., 1992; Sun et al., 1998; Nawshad and Hay,
2003) others have suggested that apoptosis (Martinez-Alvarez
et al., 2000; Cuervo and Covarrubias, 2004) or cell migration
(Carette and Ferguson, 1992) may be the major fate of the
MEE. Conflicting reports of cell tracing experiments have been
shown to either support (Griffith and Hay, 1992; Shuler et al.,
1992; Sun et al., 1998) or rule out (Vaziri Sani et al., 2005; Xu
et al., 2006) EMT, adding more confusion to this area of
research. The purpose of our work was not to provide further
support for in vivo EMT but, rather, to establish the existence
of Smad2-P–Smad4–LEF1 complexes that inhibit gene
Fig. 4. Smad2-P–Smad4–LEF1 directly bind to the promoter of the E-cadherin gene.
(A) Promoter analysis of the murine E-cadherin gene revealed one unique LEF1-binding site
(independent of the standard TCF and/or LEF site located in the E-pal) and a Smad-binding
element (SBE), both within close proximity to the E-pal LEF1-binding region. (B) Binding
of the Smad2-P–Smad4–LEF1 protein complex to the endogenous loci was confirmed by
chromatin immunoprecipitation. Chromatin was immunoprecipitated with antibodies against
IgG (negative control), LEF1, Smad4, Smad2-P or -catenin. PCR analysis using
precipitated DNA showed binding of LEF1, Smad4 and Smad2-P to LEF1 (non-E-pal), LEF1
(E-pal) and SBE regions of the E-cadherin promoter. Whereas LEF1 and Smad4 interact with
their respective binding regions, all three proteins are observed because they form a
transcription complex. No signal was observed from unfused MEE cells whereas a moderate
signal was detected from fused MEE cells that was heavily increased upon treatment with
exogenous TGF3. -catenin was not detected for interaction with these binding sites.
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expression. However, our primary MEE cells did undergo EMT
in vitro as a result of the TGF3 and Smad2-P–Smad4–LEF1-
dependent suppression of E-cadherin transcription.
Whereas others have previously described Smad3-Smad4
complexes being able to bind and functionally activate LEF1
(Labbe et al., 2000; Nishita et al., 2000), we provide the first
evidence of Smad2-Smad4-LEF1 complexes. Also, whereas
Smad-LEF1 complexes have been described to promote
transcription of reporter genes such as Xtwn (Labbe et al.,
2000), our work presents the first evidence that these
complexes can repress gene transcription. This work provides
a foundation to isolate differences between Smad-mediated and
-catenin-mediated LEF1 activation and EMT. The unique
mechanism of cell adhesion loss described here will provide
new insight into EMT in other systems of embryonic
development and pathology.
Materials and Methods
Cell Culture
Palate medial edge epithelial cells from CF-1 mouse (Charles River Laboratories)
embryos were separated from underlying mesenchyme [using dispase II (Roche)],
from unfused single palatal shelves and fused palatal shelves adhered for 12 hours
in organ culture, as previously described (LaGamba et al., 2005). Cells were then
cultured into primary cell lines in F12 media (Gibco) + 10% FBS + 1% penicillin-
streptomycin. Fetal bovine serum was removed for all experimental conditions.
Isolation of MEE cells during the peak of in vivo LEF1 expression (36 hours post
initial contact; 24 hours post established adherence) (Nawshad and Hay, 2003) could
not be achieved because of dissociation of the MEE seam. When fused cells were
removed from primary tissue, increases in TGF3 halt to only a moderate
expression that is not sufficient to induce EMT. Since TGF3 expression continually
increases during MEE dissociation (LaGamba et al., 2005), we added exogenous
TGF3 to fused cells to mimic the in vivo results. Cells were treated with
recombinant TGF3 (R&D Systems) at a concentration of 10 ng/ml for 24 hours
for all relative experiments. The dominant-negative LEF1 and dominant-negative
Smad4 plasmids (which produce proteins that lack the ability to bind DNA) were
kind gifts from M. Waterman (University of California, Irvine, CA) and D. M.
Simeone (University of Michigan, Ann Arbor, MI), respectively. All adenoviral
constructs were made using the AdEasy vector system (Adenovirus Technologies),
a gift from B. Vogelstein, (The Johns Hopkins School of Medicine, Baltimore, MD).
The above constructs have been used in our laboratory previously (Nawshad and
Fig. 5. Smad2-P–Smad4–LEF1 directly inhibits E-cadherin gene
expression. (A) Reporter gene analysis of E-cadherin promoter
activity (pGL3-E-cad-Lux) demonstrated decreased expression under
the influence of TGF3. Treatment of cells with dominant-negative
Smad4 or LEF1 (DN Smad4 or DN LEF1, respectively) prevented
the repression of E-cadherin, but antisense -catenin/-catenin
oligodeoxynucleotide (AS B-catenin ODN) did not (mean ± s.d.;
n=3; *P<0.001 compared with Unfused; **P<0.05 compared with E-
cad). (B) Site directed mutagenesis of the Smad4-binding (SBE) and
LEF1-binding (E-pal and non E-pal) regions also prevented loss of
E-cadherin promoter activity (mean ± s.d.; n=3; *P<0.001 compared
with Unfused; **P<0.01 compared with E-cad). (C) Real-time
quantitative PCR for E-cadherin gene expression relative to the
unfused MEE negative control showed a steady decrease in fused
MEE cells and fused cells treated with TGF3. DN-LEF1 and DN
Smad4 prevented this suppression, whereas AS B-catenin ODN had
no effect (mean ± s.d.; n=3; *P<0.001 compared with Unfused;
**P<0.01 compared with + TGF3).
Fig. 6. Loss of E-cadherin is associated with increased expression of
mesenchymal markers. (A) Immunocytochemistry demonstrated
progressive repression of E-cadherin from fused MEE cells to those
exposed to exogenous TGF3. Bar, 10 m. (B) E-cadherin
expression was also assessed by immunoblotting, showing a
moderate loss in fused cells, followed by a complete loss in fused
cells treated with TGF3. Dominant-negative Smad4 or LEF1 (DN
Smad4 or DN LEF1, respectively) prevented this repression, whereas
antisense -catenin/-catenin oligodeoxynucleotide (AS -catenin
ODN) had no effect. Contrarily, we found that expression of the
mesenchymal markers vimentin and Fibronectin was steadily
increased; DN Smad4 and DN LEF1 prevented these increases. AS
-catenin ODN had no effect on these proteins.
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Hay, 2003). All viruses were used at a concentration of 1:100 with treatments for
24 hours. Antisense oligodeoxynucleotide against -catenin/-catenin (AS -
catenin ODN) with the sequence 5-GTGGTCCACAGAACTTCTC-3 was used as
previously described (Kim et al., 1998). All experiments were performed in
triplicate.
Immunocytochemistry, immunoblotting, and co-
immunoprecipitation (CoIP)
The antibodies against the following proteins were used for our immunoassays: E-
cadherin (Zymed), Smad2, LEF1 (Santa Cruz Biotechnology), Smad2-P
(generously provided by P. ten Dijke, The Netherlands Cancer Institute, Amsterdam,
The Netherlands), Smad3-P (BioSource), Smad4 (Cell Signaling Technology),
fibronectin, -catenin (Transduction Laboratories), GAPDH, histone H3
(Chemicon), -catenin, vimentin, -actin (Sigma). Dilutions were used according
to the recommendation of the respective manufacturers. Fluorescein- and
Rhodamine-conjugated secondary antibodies (Pierce) were used at a concentration
of 1:250. Anti-mouse HRP-conjugated secondary antibodies (Chemicon) were used
at a 1:1000 concentration. Immunocytochemistry (Nawshad and Hay, 2003) and
immunoblotting (Li et al., 2002) experiments were conducted as described
elsewhere. Isolation of cytoplasmic and/or membrane and nuclear protein extracts
were achieved using the Compartment Protein Extraction Kit (Chemicon) and
Journal of Cell Science 120 (9)
protocol. For immunoprecipitation we used the IP50 Protein G Immunoprecipitation
Kit (Sigma) and followed the protocol as suggested by the manufacturer.
Immunocytochemistry images were acquired using a Nikon 80i fluorescence
microscope. Adjustments of image size, brightness and contrast were made using
Adobe Photoshop CS.
Promoter analysis and chromatin immunoprecipitation (ChIP)
Analysis of the murine E-cadherin gene promoter was performed using MAT
Inspector (Genomatix) software. Single-stranded oligonucleotide primers
representing forward and reverse sequences of the wild-type and mutant LEF1-and
Smad4-binding sites were commercially synthesized (IDT, Coralville, IA). The
ChIP assay was performed using ChIP-ITTM (ActiveMotif, Carlsbad CA) and its
protocol as described by the manufacturer. PCR (and real-time quantitative PCR)
analysis was performed on DNA isolated through ChIP using an ABI 7500 cycler,
with 40 cylces per sample. The following primers were used: LEF1-binding site
(non E-pal): forward, 5-CATGCCACCAACTACAGACAG-3; reverse, 5-
CTAGCAGAAGTTCTTGGGAAC-3; LEF1-binding site (E-pal): forward, 5-
TAGGAAGCTGGGAAG-3; reverse, 5-TGCGGTCGGGCAGGG-3; Smad4-
binding site (SBE): forward, 5-CCCTCTTGGTGGAAGAAGAG-3; reverse, 5-
CATCATCTAGGTTTCCG-3.
Luciferase reporter gene assays
Luciferase reporter assays were conducted using the Luciferase Assay System
(Promega) and the corresponding protocol. Light units were measured with a
Luminometer TD-20/20 (Turner Designs). Assays were normalized for transfection
efficiency by co-transfection with a -gal control plasmid and detected with the
Luminescent -gal control assay kit (Clontech). Experimental (luciferase) results
were divided by the -gal results to provide normalized values of arbitrary units.
All plasmids (500 ng) were transfected into cells using Lipofectamine and
LipofectaminePlus reagents (Invitrogen) according to the manufacturer’s guidelines.
The p3TP-Lux reporter plasmid was provided by J. Massague (Memorial Sloan-
Kettering Cancer Center, New York, NY). The pTOPFLASH-Lux and
pFOPFLASH-Lux reporter constructs were kindly provided by H. Clevers
(Netherlands Institute for Developmental Biology, Utrecht, The Netherlands). The
pGL3-E-cad-Lux luciferase construct was generously provided by S. Dedhar
(University of British Columbia, Vancouver, Canada).
Site-directed mutagenesis
A –800 bp E-cadherin gene promoter construct (generously provided by J. Behrens,
University Erlangen-Nürnberg, Erlangen, Germany) was cloned into the pGL3-Lux
reporter plasmid. Site-directed mutagenesis (Mutant-Max) was used to create
mutant –800 bp promoter constructs. One construct was mutated at the LEF1-
binding site located outside the traditional E-pal site, the second was mutated at the
Smad4-binding site, the third (kindly provided by A. Cano, Instituto de
Investigaciones Biomedicas, Madrid, Spain) was mutated at the E-pal site where
LEF1 commonly binds. The mutant sites were all confirmed by sequencing. These
constructs were then transfected into cells for luciferase assays as described above.
The following regions were mutated (mutated base are underlined). Construct 1
(LEF1, non E-pal) wild-type LEF1: 5-CTTTGTAACTCC A-3; mutant LEF1:
5-CTTGTCGACTCCA-3; construct 2 (Smad4) wild-type Smad4: 5-GGC -
CGCAGCCT-3; mutant Smad4: 5-GGCTTGAGCCT-3; construct 3 (LEF1:
E-pal) wild-type E-pal: 5-CACCTAAAGGTG-3; mutant E-pal: 5-CACCT -
TTAGGTG-3.
Real-time quantitative PCR
RNA samples were extracted using the RNeasy Mini Kit (Qiagen) and according
to the manufacturer’s protocol. Samples were submitted to a core facility
(Biopolymers Facility, Harvard Medical School, Department of Genetics) where
real-time PCR experiments were conducted using the Syber Green PCR system
(ABI) on an ABI 7500 cycler, with 40 cycles per sample. Cycling temperatures were
as follows: denaturing 95°C; annealing and extension, 60°C. The following primers
Fig. 7. TGF3 signaling promotes post-EMT cell migration of MEE
cells. (A) Scratch wound assays demonstrated lack of cell migration
in unfused or fused MEE cells. Addition of exogenous TGF3
stimulated cell migration of fused cells, whereas addition of
dominant-negative LEF1or Smad4 (DN LEF-1 or DN Smad4,
respectively) prevented migration under these conditions. Antisense
-catenin/-catenin oligodeoxynucleotide (AS -catenin ODN) did
not prevent TGF3-induced migration. Bar, 60 m. (B) Transwell
cell migration assays showed little migration of unfused or fused
MEE cells, whereas fused cells exposed to TGF3 were highly
migratory. DN Smad4 and DN LEF1 prevented migration, but AS -
catenin ODN did not (mean ± s.d.; n=3; *P<0.001 compared with
Unfused; **P<0.05 compared with + TGF3).
Fig. 8. Diagram of the proposed interaction between the Smad2-
P–Smad4–LEF1 transcription complex and the E-cadherin gene
promoter is shown to demonstrate our hypothesis of transcriptional
repression.
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were used. E-cadherin forward 5- CGTGATGAAGGTCTCAGCC-3, reverse
5-ATGGGGGCTTCATTCAC-3; GAPDH forward 5-TGAAGGTCGGTGTG -
AACGGATTTGGC-3, reverse 5-CATGTAGGCCATGAGGTCCACCAC-3.
Transwell migration assays
To assess post-EMT activities we used the InnocyteTM Cell Migration Assay (EMD
Biosciences). Transwell migration chambers (8 m pore size) in 96-well plates were
used for migration analyses. Unfused and untreated fused MEE cells were used as
negative controls. Fused MEE cells were treated with either exogenous recombinant
TGF3 alone or in combination with dominant-negative LEF1, dominant-negative
Smad4, AS -catenin ODN as described above. MEE cells were allowed to migrate
across the membrane insert towards medium in the presence of serum (10%) for 24
hours at 37°C (chemotactic migration). Cells that migrated through the membrane
attached to the lower side of the cell culture insert and were subsequently detached
using cell detachment buffer containing Calcein-AM fluorescent dye (excitation
maximum 485 nm, emission maximum 520 nm).. The data were obtained using a
standard fluorescent plate reader (BD FACSArrayTM bioanalyzer).
Scratch wound assays
Unfused (control) and fused MEE cells were grown to 100% confluence in six-well
culture plates. A straight-line-shaped wound (no cell zone) was made by scraping
the MEE cell monolayer with a sterile pipette tip to a uniformly placed scratch
among the cells. Wounded cultures were incubated for 24 hours with or without
TGF3 or in combination with dominant-negative LEF1, dominant-negative Smad4
and AS -catenin ODN as described above. Migration of cells (or gap filling) was
observed 24 hours post treatment through a phase-contrast microscope where cells
were morphologically assessed for the migratory mesenchymal morphology. The
center of the scratch line was used for positioning.
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Fig. S1. Effect of antisense β-catenin ODN. Control immunoblotting demonstrated heavily 
decreased levels of β-catenin and γ-catenin in the presence of the antisense (AS) β-catenin 
ODN in fused MEE cells. 
 
 
 
Fig. S2. Quantitative assessment of chromatin immunopreciptiation PCR signals. (A-C) 
Real-time PCR showed results similar to those observed on agarose gels, with common 
association of Smad2-P, Smad4 and LEF1 to the LEF1 (non E-pal)-binding, LEF1 (E-pal)-
binding and SBE-binding sites. These signals were increased upon exposure of cells to 
TGFβ3. Antibodies against IgG (negative control) and β-catenin showed no increase in ChIP 
signals. 
